AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Key Points: Administration of AAV8-hAAT-mdtcs vector results in sustained expression of plasma ADAMTS13 activity and antigen. The AAV8-mediated expression of ADAMTS13 variant is a safe and efficacious approach for treatment of a murine model of TTP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145 · cited 1×
“Recent clinical studies using adeno-associated virus (AAV)-based gene delivery vectors have documented safety and long-term expression of therapeutic transgenes for two human genetic diseases.(12,13) In this study, we report the safety and efficacy of AAV8mediated expression of a C-terminal truncated ADAMTS13 variant…”
BackgroundSelf-citationAdenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864
Quantification of adeno-associated virus particles and empty capsids by optical density measurement
Sommer, J. Ü. M., Smith, P. H., Parthasarathy, S., Isaacs, J., Vijay, S., Kieran, J., Powell, S. K., McClelland, A., & Wright, J. F. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00019-9 · Cited by 230
Self-citation
Cited by
ADAMTS13 and von Willebrand Factor in Thrombotic Thrombocytopenic Purpura
Zheng, X. L. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-061813-013241 · Cited by 264
Self-citationDelivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
Trepotec, Z., Lichtenegger, E., Plank, C., Aneja, M. K., & Rudolph, C. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.12.012 · Cited by 115
ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology
Cao, Y., Xu, H., Zhu, Y., Shi, M.-J., Wei, L., Zhang, J., Cheng, S., Shi, Y., Tong, H., Kang, L., et al. (2019) · PLOS Biology · doi:10.1371/journal.pbio.3000313 · Cited by 31
“Previous studies have documented the safety and long-term expression of this AAV8-mediated expression of ADAMTS13 variant in a murine model of thrombotic thrombocytopenic purpura [58].”
BackgroundRetractedmRNA treatment produces sustained expression of enzymatically active human ADAMTS13 in mice
Liu-Chen, S., Connolly, B., Cheng, L., Subramanian, R. R., & Han, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-26298-4 · Cited by 20
Metadata
- Authors
- Jin, S.-Y., Xiao, J., Bao, J., Zhou, S., Wright, J. F., & Zheng, X. L.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2013-05-09
- Volume
- 121
- Issue
- 19
- Pages
- 3825-3829
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2050244532
- Cited by
- 44
- References
- 3
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura. https://app.cochat.ai/papers/10.1182/blood-2013-02-486779
- The paper
- Jin, S.-Y., Xiao, J., Bao, J., Zhou, S., Wright, J. F., & Zheng, X. L. (2013). AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura. Blood. https://doi.org/10.1182/blood-2013-02-486779
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.